New treatments give kidney cancer patients a 3-month survival advantage
By
Mallory Hackett
Jun 23, 2019
Elderly patients with metastatic renal cell carcinoma have a three-month survival advantage with targeted therapies compared to older treatments, a new study finds.
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.